N
COMPANY PROFILE
NexCura
NexCura the first company to use scientific data from significant clinical studies to generate reports tailored to a patient's unique
Valuation
$10–25M
Last recorded · 2002
Headcount
<100
Current team size
Total funding
$10–50M
Disclosed equity funding
At a glance
- Founded
- 1998
- Headquarters
- The Woodlands, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Cardinal Venture Capital
ARCH Venture Partners
Series B and later2 investors entered at this stage
Lilly Ventures
Cardinal Partners
Team profiled
2
named & role-tagged
Founders
Hidden — book a demo/100
quality score
Key operators
Hidden — book a demo
quality score
Potential founders
Hidden — book a demo
likely future founders
Startup mafia
Hidden — book a demo
alumni-founded startups
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about NexCura on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NexCura on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.